The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
February 4 - Hedge Funds, News - Comments
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
December 8 - Hedge Funds, News - Comments
In this article, we take a look at the 5 pharmaceutical stocks to buy according to Brandon Haley’s Holocene Advisors.
Keep Reading →
December 7 - Hedge Funds, News - Comments
In this article, we discuss the 10 best healthcare stocks to buy according to Greg Martinez's Parkman Healthcare Partners.
Keep Reading →
December 4 - Hedge Funds, News - Comments
In this article, we discuss the 10 stocks that analysts are increasing price targets of.
Keep Reading →
October 29 - Hedge Funds, News - Comments
In this article, we will take a look at the 11 best genomic stocks to buy now.
Keep Reading →
October 19 - Hedge Funds, News - Comments
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Keep Reading →
October 18 - Hedge Funds, News - Comments
In this article, we will discuss 5 pharmaceutical stocks to buy today according to Tiger Cub Billionaire Lee Ainslie.
Keep Reading →
September 20 - Hedge Funds, News - Comments
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
Keep Reading →
July 6 - Hedge Funds, News - Comments
In this article we will take a look at whether hedge funds think Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is a good investment right now.
Keep Reading →
March 29 - Hedge Funds, News - Comments
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Keep Reading →
December 20 - Hedge Funds, News - Comments
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Keep Reading →
November 3 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
September 9 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
July 9 - Hedge Funds, News - Comments
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Keep Reading →
June 4 - Hedge Funds, News - Comments
We hate to say this but, we told you so.
Keep Reading →
March 18 - Hedge Funds, News - Comments
It has been a fantastic year for equity investors as Donald Trump pressured Federal Reserve to reduce interest rates and finalized the first leg of a trade deal with China.
Keep Reading →
January 8 - Hedge Funds, News - Comments
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.
Keep Reading →
December 3 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
October 22 - Hedge Funds, News - Comments
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock...
Keep Reading →
June 19 - Hedge Funds, News - Comments
"Market conditions are changing.
Keep Reading →
April 19 - Hedge Funds, News - Comments
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Keep Reading →
December 8 - Hedge Funds, News - Comments
What happened: Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a precommercial pioneer of RNA-based therapies, continued a slide that began just ahead of the weekend.
Keep Reading →
April 2 - Market Movers, News - Comments
"The S&P 500 and the Nasdaq Composite hit fresh intraday records on Monday as a jump in oil prices to a two-week high lifted Wall Street sentiment.
Keep Reading →
May 15 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
At Insider Monkey, we track more than 700 of the best hedge funds in the world and have developed various market-beating strategies over the years using the wealth of data we ...
Keep Reading →
March 16 - Hedge Funds, News - Comments
The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines.
Keep Reading →
November 30 - Hedge Funds, News - Comments
U.S indexes have opened lower this morning, as the trading week has kicked off with a plunge in global bonds courtesy of inflation fears.
Keep Reading →
October 17 - Insider Trading, News - Comments
A couple of companies have had a tough twenty-four hours in the biotech space.
Keep Reading →
October 7 - News, Stock Analysis - Comments
Many traders are watching crude futures today to see if WTI can break out of the $50 per barrel mark.
Keep Reading →
October 6 - Market Movers, News - Comments
Given the volatile nature of the markets, investors should pay attention to the latest moves made by elite hedge funds and other investors in their conviction picks, to get a ...
Keep Reading →
March 2 - Hedge Funds, News - Comments
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
Keep Reading →
December 5 - Hedge Funds, News - Comments
On August 30, The Medicines Company (NASDAQ:MDCO) and Alnylam Pharmaceuticals Inc.
Keep Reading →
August 31 - Hedge Funds, News - Comments
Bridger Management, led by Roberto Mignone, has filed its 13F with the SEC for the current reporting period.
Keep Reading →
August 18 - Hedge Fund Analysis, Hedge Funds, News - Comments
Recent research conducted at InsiderMonkey has shown that stocks bought by insiders tend to outperform market indexes.
Keep Reading →
April 8 - Insider Trading, News - Comments
Tracking insider purchases can provide an investor with great ideas, just like keeping an eye on hedge fund moves.
Keep Reading →
April 4 - Insider Trading, News - Comments
Synta Pharmaceuticals Corp.
Keep Reading →
September 11 - News - Comments
For the latest deal, Biogen Idec Inc (NASDAQ:BIIB) is giving Isis $100 million up front, and ISIS Pharmaceuticals, Inc.
Keep Reading →
September 11 - News - Comments
The health care sector has been one of the best performing sectors of 2013.
Keep Reading →
September 11 - News - Comments
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that management will present a company overview at the Morgan Stanley Global Healthcare Conference...
Keep Reading →
September 5 - News - Comments
If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era lost to time.
Keep Reading →
August 28 - News - Comments
Now, according to many market players, hedge funds are viewed as delayed, outdated financial tools of an era lost to time.
Keep Reading →
August 22 - News - Comments
If you were to ask many market players, hedge funds are seen as useless, outdated financial tools of a period lost to current times.
Keep Reading →
August 22 - News - Comments
Once upon a time in a regulatory environment far, far away, there was a cholesterol-fighting drug named Lipitor from Pfizer Inc. (NYSE:PFE).
Keep Reading →
August 21 - News - Comments
In the financial world, there are tons of indicators investors can use to watch their holdings. Some of the most under-the-radar are hedge fund and insider trading sentiment.
Keep Reading →
August 6 - News - Comments
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view.
Keep Reading →
August 6 - News - Comments
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), already quite expensive, spiked higher since takeover rumors surfaced in early July.
Keep Reading →
August 6 - News - Comments
In 2013, a number of new drugs got approvals from the FDA. This provided a boost to the biotech industry as a whole.
Keep Reading →
August 5 - News - Comments
Biotech's the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling up or down by significant amounts...
Keep Reading →
July 22 - News - Comments
According to IBISWorld, revenue of global biotechnology companies will surge to $262 billion this year, up by 12.7%, year-over-year.
Keep Reading →
July 16 - News - Comments
If you thought the fireworks ended after the Fourth of July celebrations last week, think again.
Keep Reading →
July 15 - News - Comments